The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia

Respiratory Physiology and Neurobiology

Volumn 203, Issue , 2014, Pages 60-67

  Shin, Mi Kyung ^a   Han, Woobum ^a   Bevans Fonti, Shannon ^a   Jun, Jonathan C ^a   Punjabi, Naresh M ^a   Polotsky, Vsevolod Y ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epinephrine; Insulin secretion; Sleep apnea; Type 2 diabetes

Indexed keywords

ADRENALIN; CORTICOSTERONE; FATTY ACID; GLUCAGON; GLUCOSE; INSULIN; NORADRENALIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADRENAL MEDULLECTOMY; ADRENALIN BLOOD LEVEL; ADRENALIN RELEASE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIET RESTRICTION; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIVER WEIGHT; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ADRENAL MEDULLA; ANIMAL; ANOXIA; BLOOD; C57BL MOUSE; COMPLICATION; GLUCOSE TOLERANCE TEST; METABOLIC DISEASES; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; SURGERY;

ADRENAL MEDULLA; ANIMALS; ANOXIA; BLOOD GLUCOSE; EPINEPHRINE; FASTING; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; STATISTICS, NONPARAMETRIC;

EID: 84907694325     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2014.08.018     Document Type: Article

References (79)

1. Ahren B., Lundquist I. Effects of alpha-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse. Acta Physiol. Scand. 1985, 125:211-217.
2. Alonso L.C., Watanabe Y., Stefanovski D., Lee E.J., Singamsetty S., Romano L.C., Zou B., Garcia-Ocana A., Bergman R.N., O'Donnell C.P. Simultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious unhandled mice. Obesity (Silver Spring) 2012, 20:1403-1412.
3. Andrikopoulos S., Blair A.R., Deluca N., Fam B.C., Proietto J. Evaluating the glucose tolerance test in mice. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1323-E1332.
4. Ayala J.E., Samuel V.T., Morton G.J., Obici S., Croniger C.M., Shulman G.I., Wasserman D.H., McGuinness O.P. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model. Mech. 2010, 3:525-534.
5. Bao G., Metreveli N., Li R., Taylor A., Fletcher E.C. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J. Appl. Physiol. 1997, 83:95-101.
6. Bao G., Randhawa P.M., Fletcher E.C. Acute blood pressure elevation during repetitive hypocapnic and eucapnic hypoxia in rats. J. Appl. Physiol. 1997, 82:1071-1078.
7. Barth E., Albuszies G., Baumgart K., Matejovic M., Wachter U., Vogt J., Radermacher P., Calzia E. Glucose metabolism and catecholamines. Crit. Care Med. 2007, 35:S508-S518.
8. Baruzzi A., Riva R., Cirignotta F., Zucconi M., Cappelli M., Lugaresi E. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 1991, 14:83-86.
9. Bickel P.E., Tansey J.T., Welte M.A. PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim. Biophys. Acta 2009, 1791:419-440.
10. Carlson J.T., Hedner J., Elam M., Ejnell H., Sellgren J., Wallin B.G. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993, 103:1763-1768.
11. Cheng K., Ho K., Stokes R., Scott C., Lau S.M., Hawthorne W.J., O'Connell P.J., Loudovaris T., Kay T.W., Kulkarni R.N., Okada T., Wang X.L., Yim S.H., Shah Y., Grey S.T., Biankin A.V., Kench J.G., Laybutt D.R., Gonzalez F.J., Kahn C.R., Gunton J.E. Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J. Clin. Invest. 2010, 120:2171-2183.
12. Dick T.E., Hsieh Y.H., Wang N., Prabhakar N. Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. Exp. Physiol. 2007, 92:87-97.
13. Drager L.F., Jun J.C., Polotsky V.Y. Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract. Res. Clin. Endocrinol. Metab. 2010, 24:843-851.
14. Drager L.F., Li J., Reinke C., Bevans-Fonti S., Jun J.C., Polotsky V.Y. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 2011, 19:2167-2174.
15. Drager L.F., Li J., Shin M.K., Reinke C., Aggarwal N.R., Jun J.C., Bevans-Fonti S., Sztalryd C., O'Byrne S.M., Kroupa O., Olivecrona G., Blaner W.S., Polotsky V.Y. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur. Heart J. 2012, 33:783-790.
16. Drager L.F., Togeiro S.M., Polotsky V.Y., Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J. Am. Coll. Cardiol. 2013, 62:569-576.
17. Drager L.F., Yao Q., Hernandez K.L., Shin M.K., Bevans-Fonti S., Gay J., Sussan T.E., Jun J.C., Myers A.C., Olivecrona G., Schwartz A.R., Halberg N., Scherer P.E., Semenza G.L., Powell D.R., Polotsky V.Y. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am. J. Respir. Crit. Care Med. 2013, 188:240-248.
18. Dungan K.M., Braithwaite S.S., Preiser J.C. Stress hyperglycaemia. Lancet 2009, 373:1798-1807.
19. Esler M., Jennings G., Lambert G., Meredith I., Horne M., Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev. 1990, 70:963-985.
20. Fenik V.B., Singletary T., Branconi J.L., Davies R.O., Kubin L. Glucoregulatory consequences and cardiorespiratory parameters in rats exposed to chronic-intermittent hypoxia: effects of the duration of exposure and losartan. Front. Neurol. 2012, 3:51.
21. Foster G.D., Sanders M.H., Millman R., Zammit G., Borradaile K.E., Newman A.B., Wadden T.A., Kelley D., Wing R.R., Sunyer F.X., Darcey V., Kuna S.T. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009, 32:1017-1019.
22. Gastaut H., Tassinari C.A., Duron B. Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Res. 1966, 1:167-186.
23. Gonzalez-Martin M.C., Vega-Agapito M.V., Conde S.V., Castaneda J., Bustamante R., Olea E., Perez-Vizcaino F., Gonzalez C., Obeso A. Carotid body function and ventilatory responses in intermittent hypoxia. Evidence for anomalous brainstem integration of arterial chemoreceptor input. J. Cell. Physiol. 2011, 226:1961-1969.
24. Greenberg H.E., Sica A., Batson D., Scharf S.M. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J. Appl. Physiol. 1999, 86:298-305.
25. Hartmann H., Beckh K., Jungermann K. Direct control of glycogen metabolism in the perfused rat liver by the sympathetic innervation. Eur. J. Biochem. 1982, 123:521-526.
26. Hedner J., Ejnell H., Sellgren J., Hedner T., Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?. J. Hypertens. Suppl. 1988, 6:S529-S531.
27. Heitmann J., Ehlenz K., Penzel T., Becker H.F., Grote L., Voigt K.H., Peter J.H., Vogelmeier C. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur. Respir. J. 2004, 23:255-262.
28. Henriksen J.H., Moller S., Ring-Larsen H., Christensen N.J. The sympathetic nervous system in liver disease. J. Hepatol. 1998, 29:328-341.
29. Huang J., Lusina S., Xie T., Ji E., Xiang S., Liu Y., Weiss J.W. Sympathetic response to chemostimulation in conscious rats exposed to chronic intermittent hypoxia. Respir. Physiol. Neurobiol. 2009, 166:102-106.
30. Iiyori N., Alonso L.C., Li J., Sanders M.H., Garcia-Ocana A., O'Doherty R.M., Polotsky V.Y., O'Donnell C.P. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am. J. Respir. Crit. Care Med. 2007, 175:851-857.
31. Imadojemu V.A., Mawji Z., Kunselman A., Gray K.S., Hogeman C.S., Leuenberger U.A. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007, 131:1406-1413.
32. Jaworski K., Sarkadi-Nagy E., Duncan R.E., Ahmadian M., Sul H.S. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G1-G4.
33. Jun J., Reinke C., Bedja D., Berkowitz D., Bevans-Fonti S., Li J., Barouch L.A., Gabrielson K., Polotsky V.Y. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2010, 209:381-386.
34. Jun J.C., Drager L.F., Najjar S.S., Gottlieb S.S., Brown C.D., Smith P.L., Schwartz A.R., Polotsky V.Y. Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep 2011, 34:1207-1213.
35. Jun J.C., Shin M.K., Yao Q., Bevans-Fonti S., Poole J., Drager L.F., Polotsky V.Y. Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E377-E388.
36. Kopin I.J., Lake R.C., Ziegler M. Plasma levels of norepinephrine. Ann. Intern. Med. 1978, 88:671-680.
37. Kumar G.K., Rai V., Sharma S.D., Ramakrishnan D.P., Peng Y.J., Souvannakitti D., Prabhakar N.R. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J. Physiol. 2006, 575:229-239.
38. Lafontan M., Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid Res. 2009, 48:275-297.
39. Lee E.J., Alonso L.C., Stefanovski D., Strollo H.C., Romano L.C., Zou B., Singamsetty S., Yester K.A., McGaffin K.R., Garcia-Ocana A., O'Donnell C.P. Time-dependent changes in glucose and insulin regulation during intermittent hypoxia and continuous hypoxia. Eur. J. Appl. Physiol. 2013, 113:467-478.
40. Lee E.J., Woodske M.E., Zou B., O'Donnell C.P. Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. J. Appl. Physiol. 2009, 107:290-294.
41. Lerner R.L., Porte D. Epinephrine: selective inhibition of the acute insulin response to glucose. J. Clin. Invest. 1971, 50:2453-2457.
42. Leuenberger U., Jacob E., Sweer L., Waravdekar N., Zwillich C., Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J. Appl. Physiol. (1985) 1995, 79:581-588.
43. Liggett S.B. alpha2A-adrenergic receptors in the genetics, pathogenesis, and treatment of type 2 diabetes. Sci. Transl. Med. 2009, 1. 12ps15.
44. Louis M., Punjabi N.M. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J. Appl. Physiol. 2009, 106:1538-1544.
45. Marcus N.J., Li Y.L., Bird C.E., Schultz H.D., Morgan B.J. Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor. Respir. Physiol. Neurobiol. 2010, 171:36-45.
46. Marrone O., Riccobono L., Salvaggio A., Mirabella A., Bonanno A., Bonsignore M.R. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993, 103:722-727.
47. Metz W., Forssmann W.G. Innervation of the liver in guinea pig and rat. Anat. Embryol. (Berl.) 1980, 160:239-252.
48. Narkiewicz K., Kato M., Phillips B.G., Pesek C.A., Davison D.E., Somers V.K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999, 100:2332-2335.
49. Narkiewicz K., van de Borne P.J., Cooley R.L., Dyken M.E., Somers V.K. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998, 98:772-776.
50. Nobin A., Baumgarten H.G., Falck B., Ingemansson S., Moghimzadeh E., Rosengren E. Organization of the sympathetic innervation in liver tissue from monkey and man. Cell Tissue Res. 1978, 195:371-380.
51. Oben J.A., Roskams T., Yang S., Lin H., Sinelli N., Torbenson M., Smedh U., Moran T.H., Li Z., Huang J., Thomas S.A., Diehl A.M. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 2004, 53:438-445.
52. Pamidi S., Aronsohn R.S., Tasali E. Obstructive sleep apnea: role in the risk and severity of diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2010, 24:703-715.
53. Pamidi S., Tasali E. Obstructive sleep apnea and type 2 diabetes: is there a link?. Front. Neurol. 2012, 3:126.
54. Patel K.P., Zhang K., Carmines P.K. Norepinephrine turnover in peripheral tissues of rats with heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R556-R562.
55. Pinto P., Barbara C., Montserrat J.M., Patarrao R.S., Guarino M.P., Carmo M.M., Macedo M.P., Martinho C., Dias R., Gomes M.J. Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea. BMC Pulm. Med. 2013, 13:13.
56. Polak J., Shimoda L.A., Drager L.F., Undem C., McHugh H., Polotsky V.Y., Punjabi N.M. Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. Sleep 2013, 36:1483-1490.
57. Polotsky V.Y., Li J., Punjabi N.M., Rubin A.E., Smith P.L., Schwartz A.R., O'Donnell C.P. Intermittent hypoxia increases insulin resistance in genetically obese mice. J. Physiol. 2003, 552:253-264.
58. Polotsky V.Y., Rubin A.E., Balbir A., Dean T., Smith P.L., Schwartz A.R., O'Donnell C.P. Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med. 2006, 7:7-16.
59. Prabhakar N.R., Kumar G.K., Peng Y.J. Sympatho-adrenal activation by chronic intermittent hypoxia. J. Appl. Physiol. 2012, 113:1304-1310.
60. Punjabi N.M., Beamer B.A. Alterations in glucose disposal in sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 2009, 179:235-240.
61. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R., Resnick H.E. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol. 2004, 160:521-530.
62. Punjabi N.M., Sorkin J.D., Katzel L.I., Goldberg A.P., Schwartz A.R., Smith P.L. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am. J. Respir. Crit. Care Med. 2002, 165:677-682.
63. Raghuraman G., Prabhakar N.R., Kumar G.K. Differential regulation of tyrosine hydroxylase by continuous and intermittent hypoxia. Adv. Exp. Med. Biol. 2012, 758:381-385.
64. Reinke C., Bevans-Fonti S., Drager L.F., Shin M.K., Polotsky V.Y. Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J. Appl. Physiol. 2011, 111:881-890.
65. Rosengren A.H., Jokubka R., Tojjar D., Granhall C., Hansson O., Li D.Q., Nagaraj V., Reinbothe T.M., Tuncel J., Eliasson L., Groop L., Rorsman P., Salehi A., Lyssenko V., Luthman H., Renstrom E. Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 2010, 327:217-220.
66. Ruohonen S.T., Ruohonen S., Gilsbach R., Savontaus E., Scheinin M., Hein L. Involvement of alpha2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia. Neuroendocrinology 2012, 96:51-59.
67. Savransky V., Bevans S., Nanayakkara A., Li J., Smith P.L., Torbenson M.S., Polotsky V.Y. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G871-G877.
68. Skoglund G., Lundquist I., Ahren B. Effects of alpha 1- and alpha 2-adrenoceptor stimulation and blockade on plasma insulin levels in the mouse. Pancreas 1986, 1:415-420.
69. Shin M.K., Yao Q., Jun J.C., Bevans-Fonti S., Yoo D.Y., Han W., Mesarwi O., Richardson R.A., Fu Y.Y., Pasricha P.J., Schwartz A.R., Shirahata M., Polotsky V.Y. Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxia. J. Appl. Physiol. 2014, pii:jap.01133.2013 [Epub ahead of print].
70. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest. 1995, 96:1897-1904.
71. Stamatakis K., Sanders M.H., Caffo B., Resnick H.E., Gottlieb D.J., Mehra R., Punjabi N.M. Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 2008, 31:1018-1024.
72. + channels. Br. J. Pharmacol. 2010, 159:669-677.
73. Tagaito Y., Polotsky V.Y., Campen M.J., Wilson J.A., Balbir A., Smith P.L., Schwartz A.R., O'Donnell C.P. A model of sleep-disordered breathing in the C57BL/6J mouse. J. Appl. Physiol. 2001, 91:2758-2766.
74. Wang N., Khan S.A., Prabhakar N.R., Nanduri J. Impairment of pancreatic beta cell function by chronic intermittent hypoxia. Exp. Physiol. 2013, 98:1376-1385.
75. Xu J., Long Y.S., Gozal D., Epstein P.N. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic. Biol. Med. 2009, 46:783-790.
76. Yokoe T., Alonso L.C., Romano L.C., Rosa T.C., O'Doherty R.M., Garcia-Ocana A., Minoguchi K., O'Donnell C.P. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J. Physiol. 2008, 586:899-911.
77. Zechner R., Kienesberger P.C., Haemmerle G., Zimmermann R., Lass A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J. Lipid Res. 2009, 50:3-21.
78. Ziegler M.G., Elayan H., Milic M., Sun P., Gharaibeh M. Epinephrine and the metabolic syndrome. Curr. Hypertens. Rep. 2012, 14:1-7.
79. Zoccal D.B., Simms A.E., Bonagamba L.G., Braga V.A., Pickering A.E., Paton J.F., Machado B.H. Increased sympathetic outflow in juvenile rats submitted to chronic intermittent hypoxia correlates with enhanced expiratory activity. J. Physiol. 2008, 586:3253-3265.